The Polycomb group protein EZH2 directly controls DNA methylation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The establishment and maintenance of epigenetic gene silencing is fundamental to cell determination and function. The essential epigenetic systems involved in heritable repression of gene activity are the Polycomb group (PcG) proteins and the DNA methylation systems. Here we show that the corresponding silencing pathways are mechanistically linked. We find that the PcG protein EZH2 (Enhancer of Zeste homolog 2) interacts-within the context of the Polycomb repressive complexes 2 and 3 (PRC2/3)-with DNA methyltransferases (DNMTs) and associates with DNMT activity in vivo. Chromatin immunoprecipitations indicate that binding of DNMTs to several EZH2-repressed genes depends on the presence of EZH2. Furthermore, we show by bisulphite genomic sequencing that EZH2 is required for DNA methylation of EZH2-target promoters. Our results suggest that EZH2 serves as a recruitment platform for DNA methyltransferases, thus highlighting a previously unrecognized direct connection between two key epigenetic repression systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neither did Dnmt3a, another chromatin modifying enzyme that is a PRC2 component and is frequently genetically inactivated in myeloid neoplasms (Fig. 5) (31”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [32]
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex
Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A., Wild, B., Miller, E. L., O'Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,562
Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,533
Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase
Jackson, J. P., Lindroth, A. M., Cao, X., & Jacobsen, S. E. (2002) · Nature · doi:10.1038/nature731 · Cited by 1,251
Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,245
Role of Histone H3 Lysine 27 Methylation in X Inactivation
Plath, K., Fang, J., Mlynarczyk-Evans, S. K., Cao, R., Worringer, K. A., Wang, H., de la Cruz, C. C., Otte, A. P., Panning, B., & Zhang, Y. (2003) · Science · doi:10.1126/science.1084274 · Cited by 1,195
Cited by
Items 401–500 of 1,004
DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
Jin, B., Yao, B., Li, J., Fields, C. R., Delmas, A. L., Liu, C., & Robertson, K. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0116 · Cited by 123
Endocrine disruption of the epigenome: a breast cancer link
Knower, K. C., To, S. Q., Leung, Y.-K., Ho, S.-M., & Clyne, C. D. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0513 · Cited by 110
Deb, G., Singh, A. K., & Gupta, S. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0546 · Cited by 122
Polycomb-mediated silencing in neuroendocrine prostate cancer
Clermont, P., Lin, D., Crea, F., Wu, R. C., Xue, H., Wang, Y., Thu, K. L., Lam, W. L., Collins, C. C., Wang, Y. Z., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0074-4 · Cited by 122
Maternal diet as a modifier of offspring epigenetics
Lillycrop, K. A., & Burdge, G. C. (2015) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174415000124 · Cited by 123
Epigenetic landscape required for placental development
Hemberger, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7113-z · Cited by 123
Epigenetic mechanisms governing seed development in plants
Köhler, C., & Makarevich, G. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400854 · Cited by 122
Hoang, P. H., & Landi, M. T. (2022) · Cancers · doi:10.3390/cancers14040961 · Cited by 121
Histone Modifications in Cancer Biology and Prognosis
Kurdistani, S. K. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_5 · Cited by 121
Epigenetic Changes in Pediatric Solid Tumors: Promising New Targets
Lawlor, E. R., & Thiele, C. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1921 · Cited by 122
Beke, L., Nuytten, M., Eynde, A. V., Beullens, M., & Bollen, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210248 · Cited by 121
Self-citationChen, K., Xiao, H., Zeng, J., Gan, Y., Zhou, H., Huang, C., Yao, W., Xiao, W., Hu, J., Guan, W., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2020 · Cited by 121
QSER1 protects DNA methylation valleys from de novo methylation
Dixon, G., Pan, H., Yang, D., Rosen, B. P., Jashari, T., Verma, N., Pulecio, J., Caspi, I., Lee, K., Stransky, S., et al. (2021) · Science · doi:10.1126/science.abd0875 · Cited by 107
Bahar Halpern, K., Vana, T., & Walker, M. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.573469 · Cited by 119
Epigenetic Risk Factors in PTSD and Depression
Raabe, F. J., & Spengler, D. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00080 · Cited by 93
Long noncoding RNAs in DNA methylation: new players stepping into the old game
Zhao, Y. F., Sun, H., & Wang, H. (2016) · Cell & Bioscience · doi:10.1186/s13578-016-0109-3 · Cited by 119
Epigenetic regulation of development by histone lysine methylation
Dambacher, S., Hahn, M., & Schotta, G. (2010) · Heredity · doi:10.1038/hdy.2010.49 · Cited by 120
hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing
Lee, C.-F., Ou, S., Lee, S., Chang, L.-H., Lin, R.-K., Li, Y.-S., Upadhyay, A. K., Cheng, X., Wang, Y., Hsu, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42275 · Cited by 119
Pawlyn, C., Bright, M. D., Buros, A. F., Epstein, J., Walters, Z. S., Aronson, L. I., Mirabella, F., Jones, J. R., Kaiser, M., Walker, B. A., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.27 · Cited by 119
Lee, J.-Y., Park, M. K., Park, J.-H., Lee, H. J., Shin, D. H., Kang, Y., Lee, C.-H., & Kong, G. (2013) · Oncogene · doi:10.1038/onc.2013.53 · Cited by 118
Polycomb comes of age: genome-wide profiling of target sites
Ringrose, L. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.04.010 · Cited by 118
Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesis
Bogdanović, O., Long, S. W., van Heeringen, S. J., Brinkman, A. B., Skarmeta, J. L. G., Stunnenberg, H. G., Jones, P. L., & Veenstra, G. J. C. (2011) · Genome Research · doi:10.1101/gr.114843.110 · Cited by 121
EZH2 in normal hematopoiesis and hematological malignancies
Herviou, L., Cavalli, G., Cartron, G., Klein, B., & Moreaux, J. (2016) · Oncotarget · doi:10.18632/oncotarget.6198 · Cited by 103
Tsai, C.-C., Chen, C.-L., Liu, H.-C., Lee, Y.-T., Wang, H.-W., Hou, L.-T., & Hung, S.-C. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-64 · Cited by 101
Du, ., Zhao, J., Yan, X., Huang, Y., Nicodemus, L. V., Yue, W., McCormick, R. J., & Zhu, M. (2010) · Journal of Animal Science · doi:10.2527/jas.2010-3386 · Cited by 117
Banerjee, R., Mani, R. S., Russo, N., Scanlon, C. S., Tsodikov, A., Jing, X., Cao, Q., Palanisamy, N., Metwally, T., Inglehart, R. C., et al. (2011) · Oncogene · doi:10.1038/onc.2011.141 · Cited by 117
Forging our understanding of lncRNAs in the brain
Andersen, R., & Lim, D. A. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2711-z · Cited by 116
Breast cancer epigenetics: normal human mammary epithelial cells as a model system
Hinshelwood, R. A., & Clark, S. J. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0386-3 · Cited by 119
Chapter 9 Epigenetic Gene Regulation in Cancer
Ballestar, E., & Esteller, M. (2008) · Advances in genetics · doi:10.1016/s0065-2660(07)00009-0 · Cited by 117
Self-citationTET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition
Morin, A., Goncalves, J., Moog, S., Castro‐Vega, L. J., Job, S., Buffet, A., Fontenille, M., Woszczyk, J., Gimenez‐Roqueplo, A., Letouzé, É., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.022 · Cited by 117
Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a
Li, B., Zhou, J., Liu, P., Hu, J., Jin, H. R., Shimono, Y., Takahashi, M., & Xu, G. (2007) · Biochemical Journal · doi:10.1042/bj20061873 · Cited by 115
Sasaki, M., Yamaguchi, J., Itatsu, K., Ikeda, H., & Nakanuma, Y. (2008) · The Journal of Pathology · doi:10.1002/path.2345 · Cited by 106
Rada-Iglesias, A., Ameur, A., Kapranov, P., Enroth, S., Komorowski, J., Gingeras, T. R., & Wadelius, C. (2008) · Genome Research · doi:10.1101/gr.6880908 · Cited by 102
Geng, H., Brennan, S., Milne, T. A., Chen, W.-Y., Li, Y., Hurtz, C., Kweon, S.-M., Zickl, L., Shojaee, S., Neuberg, D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0208 · Cited by 99
Koya, J., Kataoka, K., Sato, T., Bando, M., Kato, Y., Tsuruta-Kishino, T., Kobayashi, H., Narukawa, K., Miyoshi, H., Shirahige, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms10924 · Cited by 97
Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma
Tsou, P., Campbell, P. L., Amin, M. A., Coit, P., Miller, S. D., Fox, D. A., Khanna, D., & Sawalha, A. H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1813006116 · Cited by 114
Targeting DNA repair in cancer: current state and novel approaches
Klinakis, A., Karagiannis, D., & Rampias, T. N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03299-8 · Cited by 114
The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome
Duran-Ferrer, M., Clot, G., Nadeu, F., Beekman, R., Baumann, T., Nordlund, J., Marincevic-Zuniga, Y., Lönnerholm, G., Rivas-Delgado, A., Martín, S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00131-2 · Cited by 100
Kar, S., Deb, M., Sengupta, D., Shilpi, A., Parbin, S., Torrisani, J., Pradhan, S., & Patra, S. K. (2012) · Epigenetics · doi:10.4161/epi.21568 · Cited by 106
Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene
Yamashita, M., Kuwahara, M., Suzuki, A., Hirahara, K., Shinnaksu, R., Hosokawa, H., Hasegawa, A., Motohashi, S., Iwama, A., & Nakayama, T. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072000 · Cited by 102
Molecular and Cellular Insights into the Development of Uterine Fibroids
Machado-Lopez, A., Simón, C., & Mas, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168483 · Cited by 113
Epigenetic Dysregulation in Cancer
Muntean, A. G., & Hess, J. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081142 · Cited by 116
Xu, F., Li, X., Wu, L., Zhang, Q., Yang, R., Yang, Y., Zhang, Z., He, Q., & Chang, C. (2010) · Annals of Hematology · doi:10.1007/s00277-010-1128-5 · Cited by 113
Stem Cell Chromatin Patterns: An Instructive Mechanism for DNA Hypermethylation?
Ohm, J. E., & Baylin, S. B. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4210 · Cited by 102
D'Alessio, A. C., Weaver, I. C. G., & Szyf, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01120-07 · Cited by 94
RIP140 directs histone and DNA methylation to silence Ucp1 expression in white adipocytes
Kiskinis, E., Hallberg, M., Christian, M., Olofsson, M., Dilworth, S. M., White, R., & Parker, M. G. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601908 · Cited by 111
Epigenetic regulation of aging stem cells
Pollina, E. A., & Brunet, A. (2011) · Oncogene · doi:10.1038/onc.2011.45 · Cited by 111
Emerging EZH2 Inhibitors and Their Application in Lymphoma
Lue, J. K., & Amengual, J. E. (2018) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-018-0466-6 · Cited by 112
Nie, L., Wei, Y., Zhang, F., Hsu, Y.-H. E., Chan, L.-C., Xia, W., Ke, B., Zhu, C., Deng, R., Tang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13105-5 · Cited by 111
The noncanonical role of EZH2 in cancer
Huang, J., Gou, H., Yao, J., Yi, K., Jin, Z., Matsuoka, M., & Zhao, T. (2021) · Cancer Science · doi:10.1111/cas.14840 · Cited by 111
Functional Connection between Deimination and Deacetylation of Histones
Denis, H., Deplus, R., Putmans, P., Yamada, M., Métivier, R., & Fuks, F. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00285-09 · Cited by 111
Self-citationEpigenetic Control of the Genome—Lessons from Genomic Imprinting
Adalsteinsson, B., & Ferguson-Smith, A. (2014) · Genes · doi:10.3390/genes5030635 · Cited by 95
Sasaki, D., Imaizumi, Y., Hasegawa, H., Osaka, A., Tsukasaki, K., Choi, Y. L., Mano, H., Marquez, V. E., Hayashi, T., Yanagihara, K., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.028605 · Cited by 104
Jin, B., Ernst, J., Tiedemann, R. L., Xu, H., Sureshchandra, S., Kellis, M., Dalton, S., Liu, C., Choi, J.-H., & Robertson, K. D. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.017 · Cited by 101
Hematopoietic Stem Cell Development
Cullen, S. M., Mayle, A., Rossi, L., & Goodell, M. A. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416022-4.00002-0 · Cited by 110
The emerging role of DNA methylation in epileptogenesis
Kobow, K., & Blümcke, I. (2012) · Epilepsia · doi:10.1111/epi.12031 · Cited by 109
Role of DNA methylation and the DNA methyltransferases in learning and memory
Morris, M. J., & Monteggia, L. M. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/mmorris · Cited by 97
Epigenetics in Acute Myeloid Leukemia
Plass, C., Oakes, C. C., Blum, W. G., & Marcucci, G. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.04.008 · Cited by 110
Closed Chromatin Architecture Is Induced by an RNA Duplex Targeting the HIV-1 Promoter Region
Suzuki, K., Juelich, T., Lim, H., Ishida, T., Watanebe, T., Cooper, D. A., Rao, S., & Kelleher, A. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709651200 · Cited by 108
DNA methylation-based age prediction from various tissues and body fluids
Jung, S.-E., Shin, K.-J., & Lee, H. Y. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.11.175 · Cited by 94
Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs.
Malecová, B., & Morris, K. V. (2010) · PubMed · Cited by 109
Herrera-Merchan, A., Arranz, L., Ligos, J. M., de Molina, A., Dominguez, O., & Gonzalez, S. (2017) · Nature Communications · doi:10.1038/ncomms14005 · Cited by 108
Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms
Karn, J., & Mbonye, U. R. (2011) · Current HIV Research · doi:10.2174/157016211798998736 · Cited by 107
EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma
Zhang, J., Chen, L., Han, L., Shi, Z., Zhang, J., Pu, P., & Kang, C. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.003 · Cited by 107
Transcriptional gene silencing in humans
Weinberg, M. S., & Morris, K. V. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw139 · Cited by 108
EZH2 alterations in follicular lymphoma: biological and clinical correlations
Huet, S., Xerri, L., Tesson, B. M., Mareschal, S., Taix, S., Mescam-Mancini, L., Sohier, E., Carrère, M., Lazarovici, J., Casasnovas, O., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.32 · Cited by 107
Svedružić, Ž. M. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-387685-0.00006-8 · Cited by 108
Recruitment and Biological Consequences of Histone Modification of H3K27me3 and H3K9me3
Kim, J., & Kim, H. (2012) · ILAR Journal · doi:10.1093/ilar.53.3-4.232 · Cited by 86
Avan, A., Crea, F., Paolicchi, E., Funel, N., Galvani, E., Márquez, V. E., Honeywell, R. J., Danesi, R., Peters, G. J., & Giovannetti, E. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0037 · Cited by 108
Royston, K. J., Paul, B., Nozell, S. E., Rajbhandari, R., & Tollefsbol, T. O. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.04.015 · Cited by 106
Alchanati, I., Teicher, C., Cohen, G., Shemesh, V., Barr, H. M., Nakache, P., Ben-Avraham, D., Idelevich, A., Angel, I., Livnah, N., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008104 · Cited by 93
Forensic DNA methylation profiling from evidence material for investigative leads
Lee, H. Y., Lee, S. D., & Shin, K.-J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.7.070 · Cited by 89
Noer, A., Lindeman, L. C., & Collas, P. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0189 · Cited by 94
Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition
Malouf, G. G., Taube, J. H., Lu, Y., Roysarkar, T., Panjarian, S. B., Estecio, M. R., Jelínek, J., Yamazaki, J., Raynal, N. J. ‐., Long, H., et al. (2013) · Genome biology · doi:10.1186/gb-2013-14-12-r144 · Cited by 105
Yan, F., Shen, N., Pang, J., Xie, D., Deng, B., Molina, J. R., Yang, P., & Liu, S. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.380 · Cited by 104
Yu, Q., Zhou, B., Zhang, Y., Nguyen, E. T., Du, J., Glosson, N. L., & Kaplan, M. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103803109 · Cited by 91
Histone acetylation and chromatin signature in stem cell identity and cancer
Shukla, V., Vaissière, T., & Herceg, Z. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.07.012 · Cited by 104
Yu, T., Wang, Y., Hu, Q., Wu, W., Wu, Y., Wei, W., Han, D., You, Y., Lin, N., & Liu, N. (2017) · Oncotarget · doi:10.18632/oncotarget.21311 · Cited by 106
Takebayashi, S.-I., Tamura, T., Matsuoka, C., & Okano, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00899-07 · Cited by 89
Bam, M., Yang, X., Zhou, J., Ginsberg, J. P., Leyden, Q., Nagarkatti, P. S., & Nagarkatti, M. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9643-8 · Cited by 103
“For instance, it has been shown that histone trimethylation at H3K9 and H3K27 facilitates DNA methylation because the methyltransferases catalyzing H3K9 and H3K27 methylation bind to DNA methyltransferases and facilitates their recruitment to the target loci (Lehnertz et al. 2003; Vire et al. 2006).”
Fathi, A. T., & Abdel-Wahab, O. (2012) · Advances in Hematology · doi:10.1155/2012/469592 · Cited by 92
Genetic and epigenetic defects in mental retardation
Kramer, J. M., & van Bokhoven, H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.009 · Cited by 106
Acetylation- and Methylation-Related Epigenetic Proteins in the Context of Their Targets
Javaid, N., & Choi, S. (2017) · Genes · doi:10.3390/genes8080196 · Cited by 106
Coe, B. P., Thu, K. L., Aviel‐Ronen, S., Vucic, E. A., Gazdar, A. F., Lam, S. C., Tsao, M., & Lam, W. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071670 · Cited by 105
Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis
McCleary‐Wheeler, A. L., Lomberk, G. A., Weiß, F. U., Schneider, G., Fabbri, M., Poshusta, T. L., Dusetti, N., Baumgart, S., Iovanna, J., Ellenrieder, V., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.005 · Cited by 103
Epigenetic drugs as immunomodulators for combination therapies in solid tumors
Sigalotti, L., Fratta, E., Coral, S., & Maio, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.015 · Cited by 102
Loaeza‐Loaeza, J., Beltrán, A. S., & Hernández‐Sotelo, D. (2020) · Genes · doi:10.3390/genes11111336 · Cited by 102
Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2
Burdach, S., Plehm, S., Unland, R., Borkhardt, A., Staege, M. S., Müller-Tidow, C., & Richter, G. H. S. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8929 · Cited by 81
Fiskus, W. C., Buckley, K., Rao, R., Mandawat, A., Yang, Y., Joshi, R., Wang, Y., Balusu, R., Chen, J., Koul, S., et al. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.10.8213 · Cited by 104
Predicting response to epigenetic therapy
Treppendahl, M. B., Kristensen, L. S., & Grønbæk, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69737 · Cited by 97
Siddiqi, F. S., Majumder, S., Thai, K., Abdalla, M., Hu, P., Advani, S. L., White, K., Bowskill, B. B., Guarna, G., dos Santos, C. C., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014090898 · Cited by 102
Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing
Wu, X., Gong, Y., Yue, J., Qiang, B., Yuan, J., & Peng, X. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn243 · Cited by 92
Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target
Wen, Y., Cai, J., Hou, Y., Huang, Z., & Wang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.16467 · Cited by 90
Zhang, L., Deng, L., Chen, F., Yao, Y., Wu, B., Wei, L., Mo, Q., & Song, Y. (2014) · Oncotarget · doi:10.18632/oncotarget.2496 · Cited by 98
The epigenetic and transcriptional landscape of neuroendocrine prostate cancer
Davies, A., Zoubeidi, A., & Selth, L. A. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0420 · Cited by 100
Epigenetics and epigenetic alterations in pancreatic cancer.
Omura, N., & Goggins, M. (2009) · PubMed Central · Cited by 105
The role of nuclear organization in cancer
Lever, E., & Sheer, D. (2009) · The Journal of Pathology · doi:10.1002/path.2651 · Cited by 100
DNA methylation-mediated control of learning and memory
Yu, N.-K., Baek, S. H., & Kaang, B.-K. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-5 · Cited by 87
Multifaceted role of EZH2 in breast and prostate tumorigenesis: Epigenetics and beyond
Deb, G., Thakur, V. S., & Gupta, S. (2013) · Epigenetics · doi:10.4161/epi.24532 · Cited by 100
Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53
Park, E. K., Lee, J., Park, J. W., Bang, S. Y., Yi, S. A., Kim, B. K., Park, J. H., Kwon, S. H., You, J. S., Nam, S. W., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.313 · Cited by 99
Metadata
- Authors
- Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y., & Fuks, F.
- Affiliations
- Université Libre de Bruxelles (BE)
- Spanish National Cancer Research Centre (ES)
- KU Leuven (BE)
- Corresponding author
- Fuks, François
- ORCID
- Venue
- Nature
- Published
- 2005-12-14
- Volume
- 439
- Issue
- 7078
- Pages
- 871-874
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2053421436
- Cited by
- 2,204
- References
- 27
- Citations by year
- 2026: 32 · 2025: 52 · 2024: 60 · 2023: 72 · 2022: 89 · 2021: 110 · 2020: 95 · 2019: 94 · 2018: 95 · 2017: 119 · 2016: 151 · 2015: 134 · 2014: 128 · 2013: 135 · 2012: 164
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-04-12)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Fédération Wallonie-Bruxelles
- Fondation pour la Recherche Médicale
- Ministerio de Economía y Competitividad
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- EZH2, Polycomb group proteins, DNA methylation, DNA methyltransferases, polycomb repressive complex 2, epigenetic silencing, chromatin repression, promoter methylation, protein-protein interaction
- MeSH terms
- Enhancer of Zeste Homolog 2 Protein, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, HeLa Cells, Humans, Promoter Regions, Genetic, Protein Binding, Repressor Proteins, Substrate Specificity, Transcription Factors, CpG Islands, DNA Methylation, Gene Silencing, Epigenesis, Genetic, Chromatin Immunoprecipitation, Polycomb-Group Proteins, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.